IBRX icon

ImmunityBio

95 hedge funds and large institutions have $70.4M invested in ImmunityBio in 2020 Q3 according to their latest regulatory filings, with 26 funds opening new positions, 30 increasing their positions, 20 reducing their positions, and 16 closing their positions.

New
Increased
Maintained
Reduced
Closed

more first-time investments, than exits

New positions opened: | Existing positions closed:

more repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

more funds holding

Funds holding:

less ownership

Funds ownership:

44% less call options, than puts

Call options by funds: $2.68M | Put options by funds: $4.8M

45% less capital invested

Capital invested by funds: $129M → $70.4M (-$58.4M)

100% less funds holding in top 10

Funds holding in top 10: 10 (-1)

Holders
95
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$2.68M
Puts
$4.8M
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Change in
Stake
1
$14.6M
2
$12.9M
3
$4.28M
4
$3.7M
5
$3.69M
6
$2.98M
7
$2.71M
8
$2.12M
9
$1.78M
10
$1.77M
11
$1.55M
12
$1.23M
13
$1.12M
14
$873K
15
$854K
16
$785K
17
$741K
18
$669K
19
$540K
20
$507K
21
$491K
22
$435K
23
$422K
24
$400K
25
$388K